πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12403087

Topical antiviral compositions, delivery systems, and methods of using the same

Ligand Pharmaceuticals Incorporated Β· Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12403192

Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflamma

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12396994

Compositions for improving physiological function with age

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12396963

Cannabidiol-type cannabinoid compound

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12396974

Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

KetoneAid Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12396991

Biomarkers for the diagnosis and treatment of fibrotic lung disease

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12396988

Methods of using muscarinic antagonists in the treatment of depression

The Board of Regents of the University of Texas System Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398087

Methods of making bempedoic acid and compositions of the same

Esperion Therapeutics, Inc. Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12397034

Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesi

China Medical University Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398379

Compositions and methods for treating ornithine transcarbamylase deficiency

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398131

Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof

IDEAYA Biosciences, Inc. Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398123

Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflam

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398178

Collections of peptides, peptide agents, and methods of use thereof

Parabilis Medicines, Inc. Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12398197

Antibodies with engineered CH2 domains, compositions thereof and methods of using the same

Sutro Biopharma, Inc. Β· Granted Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12389931

Oyster peptide with effect of improving sexual function and preparation method thereof

CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12390512

Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumon

SHANGHAI REINOVAX BIOLOGICS CO., LTD Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12391734

PD-1 homing endonuclease variants, compositions, and methods of use

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12391643

Substituted amino-thiol and amino-disulfide compounds, and uses thereof

The Regents of the University of California Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12391750

Anti-C1S antibodies and methods of use thereof

Bioverativ USA Inc. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12389889

Mouse having a humanized cluster of differentiation 47 gene

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12390453

Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

ARCUTIS BIOTHERAPEUTICS, INC. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12390483

Compounds and methods for treating neurological and cardiovascular conditions

The Board of Regents of the University of Texas System Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12390497

Microbial strains for virus inhibition

MICROBIAL DISCOVERY GROUP, LLC Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12390419

Formulations of (R)-2-amino-3-phenylpropyl carbamate

AXSOME MALTA LTD. Β· Granted Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted